Response to Emerging Infection Leading to Outbreak of Linezolid-Resistant Enterococci

Author:

Kainer Marion A.1,Devasia Rose A.2,Jones Timothy F.1,Simmons Bryan P.3,Melton Kelley3,Chow Susan3,Broyles Joyce3,Moore Kelly L.1,Craig Allen S.1,Schaffner William4

Affiliation:

1. Tennessee Department of Health, Nashville, Tennessee, USA

2. Tennessee Department of Health, Nashville, Tennessee, USACenters for Disease Control and Prevention, Atlanta, Georgia, USA

3. Methodist University Hospital, Memphis, Tennessee, USA

4. Vanderbilt University School of Medicine, Nashville, Tennessee, USA

Publisher

Centers for Disease Control and Prevention (CDC)

Subject

Infectious Diseases,Microbiology (medical),Epidemiology

Reference34 articles.

1. Vancomycin-resistant enterococci: why are they here, and where do they come from.;Bonten;Lancet Infect Dis,2001

2. Vancomycin-resistant enterococci: a road map on how to prevent the emergence and transmission of antimicrobial resistance.;Delisle;Chest,2003

3. Enterococcus faecium bacteremia.;Stosor;Arch Intern Med,1998

4. Pfizer, Inc. Linezolid (Zyvox) [package insert]. Peapack (NJ): Pharmacia & Upjohn Company, Division of Pfizer, Inc.; 2000.

5. Food and Drug Administration. Warning letter to Pfizer: Re NDA 21–130; 21–131; 21–132 Zyvox (linezolid) injection, tablets and oral suspension MACMIS #13544, Dated July 20, 2005. Rockville (MD): US Department of Health and Human Services, FDA; 2005. [cited 2006 December 28].Available from http://www.fda.gov/cder/warn/2005/Zyvox_wl.pdf

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3